Agios Pharmaceuticals
AGIO
#5013
Rank
NZ$3.44 B
Marketcap
NZ$57.77
Share price
-1.61%
Change (1 day)
-10.21%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2026 (TTM): -NZ$0.82 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are NZ$66.04 Million. In 2025 the company made an earning of -NZ$0.83 Billion a decrease over its 2024 earnings that were of -NZ$0.75 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.82 Billion-1.64%
2025 -NZ$0.83 Billion10.9%
2024 -NZ$0.75 Billion8.75%
2023 -NZ$0.69 Billion0.63%
2022 -NZ$0.68 Billion2.81%
2021 -NZ$0.67 Billion10.58%
2020 -NZ$0.6 Billion-18.41%
2019 -NZ$0.74 Billion15.72%
2018 -NZ$0.64 Billion12.99%
2017 -NZ$0.57 Billion59.61%
2016 -NZ$0.36 Billion69.32%
2015 -NZ$0.21 Billion119.28%
2014 -NZ$94.58 Million39.22%
2013 -NZ$67.93 Million69.1%
2012 -NZ$40.18 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$18.50 B-2,327.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$54.37 B-6,645.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$17.48 B-2,205.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
-NZ$0.3 Billion-64.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$1.75 B-310.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.67 B-181.09%๐Ÿ‡บ๐Ÿ‡ธ USA